European Medicines Agency consultation: Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture

The European Medicines Agency has published a Draft guideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture (EMA/CHMP/BWP/68803/2010).

The document is available on the following webpage:

http://www.ema.europa.eu/pdfs/human/bwp/6880310en.pdf

The scope of this draft guideline is to provide guidance for the isolation on cell culture of any potential influenza vaccine virus intended for cell culture or egg-based influenza vaccine manufacture.

Your comments on this document are most welcomed by 01 September 2010 to the address elisa.pedone@ema.europa.eu.

Please kindly use the template in the link below to submit your comments:

http://www.ema.europa.eu/pdfs/human/regaffair/submitcomment.doc

We would be grateful if you could disseminate this e-mail to anyone else who might be interested in this document.

Related content: